These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 16682496)

  • 21. The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.
    Migueles SA; Laborico AC; Imamichi H; Shupert WL; Royce C; McLaughlin M; Ehler L; Metcalf J; Liu S; Hallahan CW; Connors M
    J Virol; 2003 Jun; 77(12):6889-98. PubMed ID: 12768008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.
    Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Difference in Consensus Sequence between HIV-1 Subtype A/E and Subtype B Viruses on Elicitation of Gag-Specific CD8
    Zhang Y; Murakoshi H; Chikata T; Akahoshi T; Tran GV; Nguyen TV; Gatanaga H; Nguyen KV; Oka S; Kuse N; Takiguchi M
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33361435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
    Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-A*7401-mediated control of HIV viremia is independent of its linkage disequilibrium with HLA-B*5703.
    Matthews PC; Adland E; Listgarten J; Leslie A; Mkhwanazi N; Carlson JM; Harndahl M; Stryhn A; Payne RP; Ogwu A; Huang KH; Frater J; Paioni P; Kloverpris H; Jooste P; Goedhals D; van Vuuren C; Steyn D; Riddell L; Chen F; Luzzi G; Balachandran T; Ndung'u T; Buus S; Carrington M; Shapiro R; Heckerman D; Goulder PJ
    J Immunol; 2011 May; 186(10):5675-86. PubMed ID: 21498667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition.
    Miura T; Brockman MA; Schneidewind A; Lobritz M; Pereyra F; Rathod A; Block BL; Brumme ZL; Brumme CJ; Baker B; Rothchild AC; Li B; Trocha A; Cutrell E; Frahm N; Brander C; Toth I; Arts EJ; Allen TM; Walker BD
    J Virol; 2009 Mar; 83(6):2743-55. PubMed ID: 19116253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1-specific CD4+ T-cell responses are not associated with significant viral epitope variation in persons with persistent plasma viremia.
    Koeppe JR; Campbell TB; Rapaport EL; Wilson CC
    J Acquir Immune Defic Syndr; 2006 Feb; 41(2):140-8. PubMed ID: 16394844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection.
    Hay CM; Ruhl DJ; Basgoz NO; Wilson CC; Billingsley JM; DePasquale MP; D'Aquila RT; Wolinsky SM; Crawford JM; Montefiori DC; Walker BD
    J Virol; 1999 Jul; 73(7):5509-19. PubMed ID: 10364299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice.
    Salgado M; Swanson MD; Pohlmeyer CW; Buckheit RW; Wu J; Archin NM; Williams TM; Margolis DM; Siliciano RF; Garcia JV; Blankson JN
    J Virol; 2014 Mar; 88(6):3340-52. PubMed ID: 24390323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome.
    Song H; Pavlicek JW; Cai F; Bhattacharya T; Li H; Iyer SS; Bar KJ; Decker JM; Goonetilleke N; Liu MK; Berg A; Hora B; Drinker MS; Eudailey J; Pickeral J; Moody MA; Ferrari G; McMichael A; Perelson AS; Shaw GM; Hahn BH; Haynes BF; Gao F
    Retrovirology; 2012 Oct; 9():89. PubMed ID: 23110705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
    Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic.
    Schellens IM; Navis M; van Deutekom HW; Boeser-Nunnink B; Berkhout B; Kootstra N; Miedema F; Keşmir C; Schuitemaker H; van Baarle D; Borghans JA
    AIDS; 2011 Sep; 25(14):1691-700. PubMed ID: 21681058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage.
    Chopera DR; Woodman Z; Mlisana K; Mlotshwa M; Martin DP; Seoighe C; Treurnicht F; de Rosa DA; Hide W; Karim SA; Gray CM; Williamson C;
    PLoS Pathog; 2008 Mar; 4(3):e1000033. PubMed ID: 18369479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
    Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
    J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection.
    Brumme ZL; Brumme CJ; Carlson J; Streeck H; John M; Eichbaum Q; Block BL; Baker B; Kadie C; Markowitz M; Jessen H; Kelleher AD; Rosenberg E; Kaldor J; Yuki Y; Carrington M; Allen TM; Mallal S; Altfeld M; Heckerman D; Walker BD
    J Virol; 2008 Sep; 82(18):9216-27. PubMed ID: 18614631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of cytotoxic T-lymphocyte-mediated immune selection in a dominant human leukocyte antigen-B8-restricted cytotoxic T-lymphocyte epitope in Nef.
    Maurer K; Harrer EG; Goldwich A; Eismann K; Bergmann S; Schmitt-Haendle M; Spriewald B; Mueller SM; Harrer T;
    J Acquir Immune Defic Syndr; 2008 Jun; 48(2):133-41. PubMed ID: 18391752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A nonprogressive clinical course in HIV-infected individuals expressing human leukocyte antigen B57/5801 is associated with preserved CD8+ T lymphocyte responsiveness to the HW9 epitope in Nef.
    Navis M; Schellens IM; van Swieten P; Borghans JA; Miedema F; Kootstra NA; van Baarle D; Schuitemaker H
    J Infect Dis; 2008 Mar; 197(6):871-9. PubMed ID: 18279072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD8+ and CD4+ cytotoxic T cell escape mutations precede breakthrough SIVmac239 viremia in an elite controller.
    Burwitz BJ; Giraldo-Vela JP; Reed J; Newman LP; Bean AT; Nimityongskul FA; Castrovinci PA; Maness NJ; Leon EJ; Rudersdorf R; Sacha JB
    Retrovirology; 2012 Nov; 9():91. PubMed ID: 23131037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence of CD8+ T-cell-mediated selective pressure on human immunodeficiency virus type 1 nef in HLA-B*57+ elite suppressors.
    Bailey JR; Brennan TP; O'Connell KA; Siliciano RF; Blankson JN
    J Virol; 2009 Jan; 83(1):88-97. PubMed ID: 18945771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
    Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD
    J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.